Trials / Completed
CompletedNCT02900235
Mass Balance Study of MT-3995
An Open-label, Mass Balance Study to Investigate the Absorption, Metabolism and Excretion of [14C]-MT-3995 After a Single Oral Dose to Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Tanabe Pharma Corporation · Industry
- Sex
- Male
- Age
- 35 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the absorption, metabolism and excretion of MT-3995 in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MT-3995 |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2016-09-14
- Last updated
- 2017-01-31
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02900235. Inclusion in this directory is not an endorsement.